Skip to main content
. 2016 May 20;2016(5):CD009491. doi: 10.1002/14651858.CD009491.pub2

Kuganeswaran 1999.

Methods Single‐centre parallel‐group randomized controlled trial conducted in USA
Participants 99 adults undergoing sigmoidoscopy (age 51 ± 2 years; 13 men and 35 women)
Interventions 1) Oral midazolam 7.5 mg (participants were asked to swish medication in mouth 15 times before swallowing to allow improved absorption by the oral mucosa)
2) Placebo
Outcomes Measured during the procedure:
Level of sedation using a sedation assessment scale (scores ranged from 0 = awake to 3 = asleep, responsive only to direct verbal or physical stimulus)
Numerical rating of anxiety reported by proceduralist and participant (0 = no anxiety; 10 = severe anxiety)
Discomfort/pain reported by proceduralist and participant (0 = no pain; 10 = severe pain)
Vital signs (hypotension)
Incomplete procedures
Measured after the procedure:
Participant satisfaction (refuse repeat procedure with same sedation)
Participant satisfaction (participant considered sedation was not adequate)
Anterograde amnesia (defined by number of participants who recalled the procedure)
Notes Conflicts of interest were not reported but it was noted that Roche Pharmaceuticals provided the study medications and "funded in part" the study. The role of the funder in design, analysis or reporting was not disclosed
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Random‐number table
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Double‐blind ‐ "the study medication was prepared by the inpatient pharmacy and physicians, nurses and patients were blinded to its identity"
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Double‐blind ‐ "the study medication was prepared by the inpatient pharmacy and physicians, nurses and patients were blinded to its identity"
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 2 participants withdrew before receiving medication
Selective reporting (reporting bias) Unclear risk No clear evidence that measured outcomes were not reported (trial protocols were not sought for confirmation)
Other bias Low risk None expected